Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04128020
Title Azacitidine Plus Nivolumab Following Reduced-intensity Allogeneic PBSC Transplantation for Patients With AML and High-risk Myelodysplasia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sherif Farag
Age Groups: adult | senior
Covered Countries

No variant requirements are available.